Chloasma
Chloasma
Explore linked clinical trials. Standard reference: MESH:M001331724 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treatment and Prevention of Melasma Relapses by Using 1064nm 650 Microsecond Laser | Chloasma, Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Active, not recruiting | Not applicable | 2026-10-01 | NCT06644157 | |
| Oral Tranexamic Acid Plus Triple Combination vs Triple Combination Alone in Melasma | Chloasma, Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Not yet recruiting | Phase 4 | 2026-07-28 | NCT07732192 | |
| A Clinical Study to Evaluate the Efficacy in Improving Dark Spots After 8 Weeks of Use of Facial Sunscreens in Adult Participants | Chloasma, Hyperpigmentation, Melanosis, Post-Inflammatory Hyperpigmentation, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Recruiting | Not applicable | 2026-07-01 | NCT07679945 | |
| Microfocused Ultrasound for Facial Pigmentary Diseases and Rosacea | Chloasma, Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, lichen planus pigmentosus, rosacea, skin disorder, skin pigmentation disorder | Active, not recruiting | Not applicable | 2026-06-30 | NCT07667972 | |
| Comparative Efficacy of Intralesional Tranexamic Acid Versus Mandelic Acid Peel in the Treatment of Melasma | Chloasma, Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Not yet recruiting | Not applicable | 2026-05-28 | NCT07604844 | |
| Comparative Effects Of Trichloroacetic Chemical Peel And Fractional Laser | Chloasma, Hyperpigmentation, Hypertrophy, Melanosis, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Active, not recruiting | Not applicable | 2026-05-19 | NCT07036302 | |
| Injectable Platelet-Rich Fibrin Versus Intradermal Tranexamic Acid for Melasma | Chloasma, Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Recruiting | Not applicable | 2026-04-22 | NCT07540702 | |
| Clinical Efficacy and Mechanisms of a Topical Azone-Tranexamic Acid-Aloe Polysaccharide Gel in the Treatment of Melasma | Chloasma, Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Not yet recruiting | Not applicable | 2026-04-14 | NCT07530016 | |
| Comparison Between Efficacy of Topical Tranexamic Acid Vs Topical Ethyl Ascorbic Acid In Treatment Of Melasma | Chloasma, Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Not yet recruiting | Phase 4 | 2026-04-13 | NCT07522788 | |
| Comparative Evaluation of Topical Metformin and Topical Tranexamic Acid in Melasma | Chloasma, Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Not yet recruiting | Not applicable | 2026-03-27 | NCT07495748 | |
| Comparative Evaluation of Topical 30% Metformin and Kligman's Regimen in Women With Melasma | Chloasma, Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Not yet recruiting | Not applicable | 2026-03-20 | NCT07485777 | |
| Evaluation of the Efficacy of Oral Tranexamic Acid and Glutathione-assisted Microneedling in Treatment of Melasma | Chloasma, Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Not yet recruiting | Phase 2 / Phase 3 | 2026-03-04 | NCT07448415 | |
| Evaluation of Efficacy and Tolerabilty of MelaB3 Serum in Combination of 35% Glycolic Acid Peeling Compared to 35% Glycolic Acid Peeling Alone in Various Hyperpigmentation Conditions | Chloasma, Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Not yet recruiting | Not applicable | 2026-02-24 | NCT07429786 | |
| Expert Consensus on the Clinical Management of Melasma: A Delphi Method Study | Chloasma, Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Enrolling by invitation | Not stated | 2025-12-29 | NCT07296549 | |
| Secretome TGF Beta 3 | Chloasma, Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Not yet recruiting | Not applicable | 2025-08-22 | NCT07137130 | |
| Efficacy and Safety of a Combined Serum Containing Melasyl™, 10% Niacinamide, Hyaluronic Acid, and HEPES | Chloasma, Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Not yet recruiting | Not applicable | 2025-08-13 | NCT07121439 | |
| Comparative Efficacy of Resveratrol 1 % Gel and Trichloroacetic Acid 20% in Treatment of Melasma: A Split-face Study | Chloasma, Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Not yet recruiting | Not applicable | 2025-07-11 | NCT07060157 | |
| Effectiveness of Oral Melatonin vs Oral Tranexamic Acid in the Treatment and Recurrence of Melasma | Chloasma, Disease Attributes, Hyperpigmentation, Melanosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Active, not recruiting | Phase 4 | 2025-06-24 | NCT07034560 | |
| Topical Metformin Versus Topical Ketotifen in Melasma Treatment | Chloasma, Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Not yet recruiting | Phase 2 | 2025-04-24 | NCT06942390 | |
| Oral Metformin for Treating Melasma in Latin American Women | Chloasma, Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Recruiting | Phase 1 / Phase 2 | 2025-02-25 | NCT06845540 | |
| Comparison of Effectiveness and Safety of Triple Combination Cream of Fucinolone Acetonide 0.01%, Hydroquinone 4%, Tretinoin 0.05% with Mometasone Furoate 0.1%, Hydroquinone 4%, Tretinoin 0.05% in the Treatment of Melasma | Chloasma, Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Not yet recruiting | Not applicable | 2025-01-17 | NCT06780644 | |
| Clinical Evaluation and Study of the Efficacy of a Centella Asiatica-Infused Facial Mask on Discosmetic Dermatosis | Acneiform Eruptions, Chloasma, Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, acne, rosacea, sebaceous gland disorder, skin disorder, skin pigmentation disorder | Not yet recruiting | Not applicable | 2025-01-08 | NCT06763367 | |
| Randomized Study Using SM-030 Gel for Adults With Melasma | Chloasma, Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Recruiting | Phase 2 | 2024-12-13 | NCT06454747 | |
| LaseMD System for the Treatment of Melasma | Chloasma, Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Active, not recruiting | Not applicable | 2019-03-13 | NCT03456674 |